American Association for Thoracic Surgery (AATS) American Association for Thoracic Surgery (AATS)
 
Home | About Us | Contact Us
 
Surgical outcome for patients with the aortic atresia-mitral stenosis variant of hypoplastic left heart syndrome

Vladimiro L. Vida, Kimberlee Gauvreau, Adam Dorfman, Alesandro Larrazabal, Frank Pigula, Emile A. Bacha, John E. Mayer, Pedro J. Del Nido, Francis Fynn-Thompson; Children's Hospital of Boston, Boston, MA


Objective: Although the overall surgical results for the management of hypoplastic left heart syndrome (HLHS) have improved considerably over the last decade, patients with aortic atresia and mitral stenosis (AA/MS) continue to present a particularly high surgical risk. We sought to define specific anatomic and preoperative characteristics that placed this anatomic subgroup at increased perioperative risk.

Methods: From January 2001 to December 2005, all patients with the AA/MS variant of HLHS who underwent surgical palliation were retrospectively reviewed. We evaluated preoperative echocardiographic data, operative characteristics and postoperative factors associated with death. Kaplan-Meier analysis was used to assess survival.

Results: Thirty-two of 143 patients (22%) who underwent first stage palliative procedure for HLHS had AA/MS. Hospital mortality for patients with AA/MS was significantly higher than for other anatomic subgroups (p=0.004). Coronary artery-to-left ventricle fistulae (CAF) were present in 14 of the 32 patients (44%) and were associated with a significantly higher hospital (p=0.04) as well as inter-stage (p=0.02) mortality. At first stage surgical palliation, 21 patients (64.5%) had a modified Blalock-Taussig shunt while 11 patients (35%) had a right ventricle to pulmonary artery (Sano) conduit. No difference in outcome was demonstrated between these two groups. Twenty-four patients (75%) had delayed sternal closure, and 6 (19%) required post-operative extra-corporeal membrane oxygenation (ECMO) support. A longer cardio-pulmonary bypass time (p=0.006), longer circulatory arrest time (p=0.006), and the need for postoperative ECMO support (p=0.001) were associated with a higher mortality rate. Inter-stage and mid-term survival after initial surgical palliation were significantly better (p=0.008 and p=0.001 respectively) in patients who did not have CAF.

Conclusion: Surgical management for patients with AA/MS variant of HLHS continues to be challenging. The presence of CAF seems to be associated with a higher hospital, inter-stage and mid-term mortality after surgical palliation.


Back to Annual Meeting
Back to Program Outline

 
   Home | About Us | Contact Us | Policies
Copyright© American Association for Thoracic Surgery.
All rights reserved. IMPORTANT REMINDER: The preceding information is intended only to provide
general guidance and not as a definitive basis for diagnosis or treatment in any particular case.
It is very important that you consult a doctor about any specific medical problem or question.